Author

Keith D. Krewer

Institutions: Mayo Clinic, St. Luke's Hospital

Observed institutions: Mayo Clinic, St. Luke's Hospital

OpenAlex ID: A5000683422

Paclitaxel and G-CSF in Previously Untreated Patients With Extensive Stage Small-Cell Lung Cancer

1999 · Ron J. Kirschling, Joseph P. Grill, et al. · American Journal of Clinical Oncology · 52

Pharmacogenetic dosing by UGT1A1 genotype as first-line therapy for advanced small-bowel adenocarcinoma: A North Central Cancer Treatment Group (NCCTG) trial.

2012 · Robert R. McWilliams, Michelle R. Mahoney, et al. · Journal of Clinical Oncology · 10

Topotecan and Paclitaxel in Previously Treated Patients with Relapsed Small Cell Lung Cancer: Phase II Trial of the North Central Cancer Treatment Group

2006 · Grace K. Dy, James R. Jett, et al. · Journal of Thoracic Oncology · 7

Works count: 3

Citation count: 69

H-index: 3

I10-index: 2